Obstructive sleep apnea syndrome (OSAS) is characterized with upper airway collapsibility during sleep resulting in repetitive cessation or significant decrease in inspiratory airflow in the presence of respiratory effort, and accompanied with excessive daytime sleepiness. Diagnosis of OSAS is based on patient history, clinical examination and sleep recording. Untreated OSAS increases the risk of cardiovascular diseases, traffic accidents, lost work days and mortality. In obese patients, weight loss forms the basis of treatment. Continuous positive airway pressure (CPAP) therapy is the treatment of choice in moderate/severe OSAS. In selected cases, oral appliances, positional therapy or surgical treatment are of benefit.
Tarja Saaresranta (Chair)